Author:
Cataldi Mauro,Cignarelli Angelo,Giallauria Francesco,Muscogiuri Giovanna,Barrea Luigi,Savastano Silvia,Colao Annamaria,
Publisher
Springer Science and Business Media LLC
Reference120 articles.
1. Di Angelantonio E, Bhupathiraju ShN, Wormser D, Gao P, Kaptoge S. Global BMI Mortality Collaboration et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet.2016;388:776–86.
2. Ma C, Avenell A, Bolland M, Hudson J, Stewart F, Robertson C, et al. Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ. 2017;359:j4849.
3. Carbone S, Lavie CJ, Arena R. Obesity and heart failure: focus on the obesity paradox. Mayo Clin Proc. 2017;92:266–79.
4. LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA. Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: an updated systematic review for the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018. AHRQ Publication No. 18-05239-EF-1 September 201, https://www.ncbi.nlm.nih.gov/books/NBK532379/pdf/Bookshelf_NBK532379.pdf.
5. Nissen SE, Wolski KE, Prcela L, Wadden T, Buse JB, Bakris G, et al. Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors: a randomized clinical trial. JAMA. 2016;315:990–1004.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献